New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
07:38 EDTCICigna shares likely up 5% or more on deal, says JPMorgan
JPMorgan expects shares of Cigna to be up 5% or more after the company announced a deal with Berkshire Hathaway to exit its Variable Annuity Death Benefits and Guaranteed Minimum Income Benefit reinsurance runoff businesses. The firm finds the deal terms favorable for Cigna and says the annoucnement removes an overhang on the stock’s valuation. JPMorgan keeps an Overweight rating on Cigna shares.
News For CI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 10, 2016
07:15 EDTCILeerink to hold a conference
Subscribe for More Information
February 9, 2016
12:15 EDTCIAddus HomeCare served with 'whistleblower' suit over referrals
Subscribe for More Information
February 8, 2016
09:38 EDTCICigna enters into outcomes-based contract with Novartis
Cigna (CI) has entered into an outcomes-based contract with the pharmaceutical company Novartis (NVS) for the drug Entresto, which was approved by the FDA for the treatment of heart failure with reduced ejection fraction. The pay-for-performance agreement ties the financial terms to how well the drug improves the relative health of Cigna's customers. The primary metric is reduction in the proportion of customers with heart failure hospitalizations. This agreement is effective for Cigna's commercial business. Entresto is a preferred brand subject to prior authorization review. The prior authorization process is part of utilization management to help control prescription drug costs and ensure coverage of the most appropriate drug therapies.
February 7, 2016
14:45 EDTCILeerink healthcare services analyst holds analyst/industry conference call
Subscribe for More Information
February 4, 2016
06:16 EDTCICigna reports Q4-end Commercial customers 14.43M, Government customers 567K
Reports Q4 Total Commercial medical care ratio of 80.4%, Total Government medical care ratio of 83.1%. Full year medical cost trend for our total U.S. Commercial book of business was approximately 5% and reflects continued favorable medical costs, physician engagement and low utilization trend.
06:15 EDTCICigna unlikely to make further share repurchases in 2016
Cites the pending combination with Anthem.
06:03 EDTCICigna sees FY16 adjusted EPS $8.85-$9.25, consensus $9.30
Subscribe for More Information
06:02 EDTCICigna reports Q4-end global medical customers 14.99M
Subscribe for More Information
06:01 EDTCICigna reports Q4 adjusted EPS $1.87, consensus $1.80
Reports Q4 revenue $9.53B, consensus $9.52B.
February 3, 2016
14:48 EDTCINotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Philip Morris (PM), consensus 81c... AstraZeneca (AZN), consensus 88c... Occidental Petroleum (OXY), consensus (12c)... ConocoPhillips (COP), consensus (65c)... Cigna (CI), consensus $1.80... Intercontinental Exchange (ICE), consensus $3.01... Boston Scientific (BSX), consensus 25c... Charter Communications (CHTR), consensus (12c)... Ralph Lauren (RL), consensus $2.13... Dunkin' Brands (DNKN), consensus 50c... GrubHub (GRUB), consensus 14c... Level 3 (LVLT), consensus 53c... AmerisourceBergen (ABC), consensus $1.25... Cummins (CMI), consensus $2.11.
06:55 EDTCICigna volatility elevated into Q4 and outlook
Cigna February call option implied volatility is at 28, March is at 29 ; compared to its 52-week range of 18 to 39, suggesting large near term price movement into the expected release of Q4 results on February 4.
January 29, 2016
14:24 EDTCIEarnings Watch: Aetna down 9% since last report
Aetna (AET) is scheduled to report fourth quarter earnings before the market open on Monday, February 1, with a conference call scheduled for 8:30 am ET. Aetna, a diversified health care benefits company in the United States, operates in three segments: Health Care, Group Insurance, and Large Case Pensions. EXPECTATIONS: Analysts are looking for earnings per share of $1.21 on revenue of $14.93B, according to First Call. The consensus range for EPS is $1.16-$1.32 on revenue of $14.44B-$15.36B. LAST QUARTER: Aetna reported third quarter EPS of $1.90 on revenue of $14.97B against analyst estimates of $1.77 and $14.95B, respectively. The company raised its fiscal 2015 EPS view to $7.45-$7.55 from "at least $7.40." Operating earnings were $668.6M for Q315 compared with $638.6M for Q314. The increase in operating earnings was primarily due to higher underwriting margins in Aetna's Health Care segment, partially offset by an increase in general and administrative expenses and lower underwriting margins in Aetna's Group Insurance segment. On January 11, Aetna said it see FY15 EPS at the high end of the $7.45-$7.55 range. Consensus for FY15 EPS is $7.54. STREET RESEARCH: On January 15, Wells Fargo said it expects health insurers' stock to do well this year, as the firm expects M&A deals made the last years to increase profits this year, and it thinks investors should be attracted to what it sees as the defensive names in the sector. Wells does not believe that any changes to or replacements of the ACA will be worse for the sector than the status quo. It identified Aetna and HCA Holdings (HCA) as its favorite names in the sector. On January 25, Leerink analyst Ana Gupte said she believed the recent selloff has provided a "strong" buying opportunity in the Managed Care space. Valuations are attractive on multiple metrics, Gupte told investors in a research note. Her top picks are UnitedHealth (UNH), Aetna, Humana (HUM) and Molina Healthcare (MOH). The analyst also favors Anthem (ANTM) and Cigna (CI). PRICE ACTION: Shares of Aetna are down approximately 9% since its last earnings report. The stock is up 2.6% to $101.42 in Friday afternoon trading ahead of Monday morning's report.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use